Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

Go back to Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 42.92 --0 (-0%)
Previous Close $42.92    52 Week High $26.84 
Open $42.92    52 Week Low $9.51 
Day High $42.92    P/E N/A 
Day Low $42.92    EPS $-2.62 
Volume 265